| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/22/2009 | CA2415386C Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives |
| 12/22/2009 | CA2411568C Compositions for the therapy of dementias |
| 12/22/2009 | CA2406081C Administration of a thiol-based chemoprotectant compound |
| 12/22/2009 | CA2402421C Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 12/22/2009 | CA2387973C Pharmaceutical formulation containing tolterodine and its use |
| 12/22/2009 | CA2362381C Amide compounds and medicinal use thereof |
| 12/22/2009 | CA2327465C Bipolar lipids capable of delivering polyanions to cells |
| 12/22/2009 | CA2307879C Treatment of t-helper cell type 2 mediated immune diseases |
| 12/22/2009 | CA2214636C Use of leukemia inhibitory factor and endothelin antagonists |
| 12/22/2009 | CA2173839C Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 12/22/2009 | CA2133833C Method and kit for imaging and treating organs and tissues |
| 12/19/2009 | CA2633246A1 Identification of therapeutic agents for hiv infection |
| 12/17/2009 | WO2009152458A1 Liquid formulation suitable for infusion comprising an adenosine receptor antagonist for treating heart failure and renal insufficiency. |
| 12/17/2009 | WO2009152415A2 Reducing myocardial reperfusion injury by the combination therapy of protein kinase a activation and b1-adrenergic receptor blockade |
| 12/17/2009 | WO2009152374A2 Method for treating chronic wounds |
| 12/17/2009 | WO2009151910A2 Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer |
| 12/17/2009 | WO2009151456A1 Thiazole compounds, and compositions and methods using same |
| 12/17/2009 | WO2009150405A1 Combination of spacitabine (cndac) and dna methyltransferase inhibitors such as decitabine and procaine |
| 12/17/2009 | WO2009150257A2 Compositions for treating rosacea |
| 12/17/2009 | WO2009124552A3 Use of a combination of hypothermia inducing drugs |
| 12/17/2009 | WO2009106574A3 Combination comprising a cannabinoid receptor binding compound and an opioid |
| 12/17/2009 | WO2009091538A8 Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia |
| 12/17/2009 | WO2009027644A3 Compositions for the treatment of neoplastic diseases |
| 12/17/2009 | WO2008129308A3 Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss |
| 12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
| 12/17/2009 | US20090312390 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 12/17/2009 | US20090312350 Compositions comprising balaglitazone and further antidiabetic compounds |
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/17/2009 | US20090311350 Compositions for alleviating inflammation and oxidative stress in a mammal |
| 12/17/2009 | US20090311340 Use of xenon as neuroprotectant in a neonatal subject |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311277 Nucleic acid compositions for stimulating immune responses |
| 12/17/2009 | US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 12/17/2009 | US20090311215 Method for treating cervical cancer |
| 12/17/2009 | US20090311199 Use of Hydrogen Peroxide-Producing Bacteria for Tooth Whitening |
| 12/17/2009 | DE102008029072A1 Substance, which inhibits serum and glucocorticoid dependent kinase 3, useful for the prophylaxis and/or treatment or diagnosis of age-related diseases e.g. arteriosclerosis, skin atrophy, myasthenia, infertility, stroke and kyphosis |
| 12/17/2009 | CA2731138A1 Compositions for treating rosacea |
| 12/17/2009 | CA2727595A1 Thiazole compounds, and compositions and methods using same |
| 12/17/2009 | CA2727432A1 Method for treating chronic wounds with an extracellular polymeric substance solvating system |
| 12/17/2009 | CA2725295A1 Combination of spacitabine (cndac) and dna methyltransferase inhibitors such as decitabine and procaine |
| 12/16/2009 | EP2133693A1 Evaluation method and screening method for substance having action of activating/suppressing innate immunity, agent and food product for activating/suppressing innate immune mechanism and method for producing the same |
| 12/16/2009 | EP2133332A1 (aza)indole derivative and use thereof for medical purposes |
| 12/16/2009 | EP2133331A1 5-membered heterocyclic derivative and use thereof for medical purposes |
| 12/16/2009 | EP2133097A1 Transpulmonary liposome for controlling drug arrival |
| 12/16/2009 | EP2133095A1 Pharmaceutical composition |
| 12/16/2009 | EP2133094A1 Pharmaceutical composition |
| 12/16/2009 | EP2133093A1 Remedy for chemotherapy-resistant cancer containing hla class i-recognizing antibody as the active ingredient and use of the same |
| 12/16/2009 | EP2133083A1 Therapeutic agent for infectious skin or mucosal disease |
| 12/16/2009 | EP2132568A1 Method of determining risk of scoliosis |
| 12/16/2009 | EP2131863A1 A method of treating malignant mesothelioma |
| 12/16/2009 | EP2131857A2 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
| 12/16/2009 | EP2131836A1 Combination of imidazo ý1,5-a¨pyrazinyl derivatives with an agent that inhibits serine phosphorylation of irs1 for use in the treatment of cancer |
| 12/16/2009 | EP1521832B1 Anti-fragilis antibody and uses thereof |
| 12/16/2009 | EP1434603B1 Method of treatment using ligand-immunogen conjugates |
| 12/16/2009 | EP1429602B1 Methods for treating disorders using plant extracts |
| 12/16/2009 | EP1425028B1 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 12/16/2009 | EP1390029B1 Phenylindoles for the treatment of hiv |
| 12/16/2009 | EP0996455B1 Alpha-o-linked glycoconjugates with clustered (2,6)-st epitopes, methods of preparation and uses thereof |
| 12/16/2009 | CN101605571A Therapeutical uses of eslicarbazepine |
| 12/16/2009 | CN101605547A Methods of treating chronic inflammatory diseases using a GM-CSF antagonist |
| 12/16/2009 | CN101605542A Pharmaceutical compositions and their methods of use |
| 12/16/2009 | CN101605529A Stable formulations, and methods of their preparation and use |
| 12/16/2009 | CN101601862A Application of porous starch and derivatives thereof as medicament carrier |
| 12/16/2009 | CN101601857A Use of low-dose erythropoietin for stimulating endothelial precursor cells, regenerating organs, and slowing down progression of end organ damages |
| 12/16/2009 | CN101601675A Pregnane steroids for use in the treatment of CNS disorders |
| 12/16/2009 | CN101601674A Pregnane steroids for use in the treatment of cns disorders |
| 12/16/2009 | CN100569296C Anticancer prior-medicine and method for preparing the same and use thereof |
| 12/16/2009 | CN100569294C Superregulated long-cycled lipid emulsion carrying medicine reagent for mainline |
| 12/16/2009 | CN100569291C Compositions containing alpha-2-adrenergic agonist components |
| 12/16/2009 | CN100569289C Anticancer medicine composition of platinum compound and clorfarabine |
| 12/16/2009 | CN100569288C Solid tumor treating medicine composition |
| 12/16/2009 | CN100569281C Preparation and use of compositions for treating and preventing necrosis |
| 12/16/2009 | CN100569235C Combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD |
| 12/15/2009 | US7632872 Providing analgesia in a newborn subject, the method comprising administering to the subject or to the mother a therapeutically effective amount of xenon |
| 12/15/2009 | US7632828 1-Methyl, 2-((2-(2-(guanidinoethyl(dimethylammonium)ethyl-)(naphthyl-1,5-ylene)oxymethyl-),6-(1-hydroxyethyl-)carbapen-2-em-3-carboxylate; 1-methylcarbapenems as bactericides; drug resistance; multidrug resistance; methicillin-resistant Staphylococcus aureus (MRSA) and S. epidermidis(MRSE) |
| 12/15/2009 | US7632826 Use of agonists of the glucocorticosteroid and/or mineralo-corticosteroid receptors, in particular corticosteroids for the treatment of addiction |
| 12/15/2009 | US7632815 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals |
| 12/15/2009 | US7632813 Administering N-(3-{2-[3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-tetrahydro-2H-pyran-4-ylpropyl)cycloheptanecarboxamideas an inhibitor and a type of parathyroid hormone to treat and/orprevent bone metabolic diseases |
| 12/15/2009 | US7632518 Microencapsulated oil |
| 12/15/2009 | US7632511 Yeast-based therapeutic for chronic hepatitis C infection |
| 12/15/2009 | CA2399087C Use of retinoid-type compounds as antibacterial agents |
| 12/15/2009 | CA2398908C Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 12/15/2009 | CA2386782C Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 12/15/2009 | CA2348445C Compositions for the treatment and prevention of cardiovascular diseases |
| 12/15/2009 | CA2347905C P53 antisense agent and method |
| 12/15/2009 | CA2344049C Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 12/15/2009 | CA2338000C Water-soluble 4-thio-maleimido derivatives and methods for their production |
| 12/15/2009 | CA2336773C Component b as angiogenic agent in combination with human growth factors |
| 12/15/2009 | CA2335617C Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv |
| 12/15/2009 | CA2295195C Compositions and methods for preventing restenosis following revascularization procedures |
| 12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
| 12/15/2009 | CA2209315C Gibberellins compounds for veterinary and medicinal applications |
| 12/10/2009 | WO2009148148A1 Neuroinvasion inhibitor |
| 12/10/2009 | WO2009148137A1 Nucleic acid capable of controlling degranulation of mast cell |
| 12/10/2009 | WO2009148058A1 Process for production of microcapsules by use of solid fat |
| 12/10/2009 | WO2009147831A1 Method and pharmaceutical composition for treatment of mental disorders |
| 12/10/2009 | WO2009147781A1 Antitumor agent |
| 12/10/2009 | WO2009147695A1 Anticancer agent |
| 12/10/2009 | WO2009147681A1 Pharmaceutical compositions for treatment of parkinson's disease |
| 12/10/2009 | WO2009147637A1 Compositions comprising amino acids, with pro-angiogenic activity |